OsseoSeal Mineralized Cortico-Cancellous (50/50) Bone in Syringe [1cc:2x0.5cc]

Where this fits in the regenerative sequence: OsseoSeal Mineralized Cortico-Cancellous Bone (1cc) is placed during the grafting phase following extraction site debridement or defect preparation, when clinicians require additional graft volume or prefer to divide material across multiple sites.

Why clinicians select split-volume cortico-cancellous grafts

• Chosen for its 50/50 cortical and cancellous composition, balancing structural stability with manageable handling characteristics.
• Commonly selected when multiple sockets or localized defects are treated in a single appointment.
• Preferred when separate syringes support controlled use and reduced material waste across procedures.

In-use behavior

In use, the mineralized particulate demonstrates stable handling with controlled delivery, allowing clinicians to place graft material directly into contained sites while maintaining graft position prior to membrane placement or closure.

Clinical context

This configuration is commonly incorporated into regenerative workflows such as multi-socket preservation, staged grafting procedures, and localized ridge augmentation, where flexibility in material use is preferred over single-syringe volume.

Technical snapshot

• Mineralized cortico-cancellous bone graft
• 50% cortical / 50% cancellous composition
• Preloaded syringes for controlled delivery
• Total volume: 1.0 cc
• Packaging: 2 × 0.5 cc syringes
• Designed for flexible, multi-site regenerative procedures

ApexDent note: OsseoSeal Mineralized Cortico-Cancellous Bone (1cc, 2 × 0.5cc) is selected when clinicians want balanced graft handling with the flexibility to treat multiple sites while maintaining controlled placement.